What the research says. What your body may be telling you. And what your options are.
Breast Implant Illness (BII) is a collection of systemic symptoms — including chronic fatigue, brain fog, joint and muscle pain, hair loss, skin rashes, anxiety, and autoimmune-like reactions — reported by women with breast implants, often developing months or years after placement and often resolving after explant. A 2025 meta-analysis of 6,048 patients found that 81.9% reported symptom improvement after explant surgery.
BII is not yet a formal medical diagnosis in the FDA's classification system. That distinction matters clinically — but it does not mean the condition doesn't exist. The FDA has logged over 10,000 Medical Device Reports describing these systemic symptoms in association with breast implants. The reports span all major manufacturers, all implant types, and patients with no prior history of autoimmune disease.
That 81.9% figure is not a placebo effect. That is a pattern that demands a serious clinical response.
Dr. Baley takes BII seriously — not because it is a popular position, but because the data justifies it. Every patient presenting with BII concerns receives a thorough assessment without minimization or dismissal.
BIA-ALCL (Breast Implant-Associated Anaplastic Large Cell Lymphoma) is a distinct condition from BII — and a more serious one. It is a rare form of T-cell lymphoma that develops in the fluid or tissue surrounding breast implants, not in the breast tissue itself. It is not breast cancer.
FDA data documents more than 60 deaths globally from BIA-ALCL. The overwhelming majority of cases — over 90% when manufacturer history is known — are associated with textured implants, particularly the Allergan BIOCELL surface, which Allergan voluntarily recalled in 2019 following FDA action.
The risk is not evenly distributed across implant types. Polytech polyurethane implants — used in the rePlantation® protocol — have a significantly better safety profile. A 5-year study of 919 patients found zero BIA-ALCL cases with Polytech PU implants, consistent with the globally reported figure of 2 confirmed cases out of over 400,000 implants placed worldwide.
If you currently have textured implants — regardless of symptoms — a specialist evaluation is warranted. Dr. Baley performs complete capsulectomy as standard practice and sends all tissue to pathology. Results are reviewed directly with you, not filed and forgotten.
Every patient presents differently. Your anatomy, your implant history, your symptoms, and your goals all shape which approach Dr. Baley recommends. After a thorough consultation, you will receive a clear recommendation — with the reasoning behind it.
This is not a diagnostic tool — only a qualified physician can assess your case. But the following symptoms are commonly reported in association with breast implants. If you recognize several of these, a specialist consultation is worth having.
Persistent, unexplained exhaustion not relieved by rest. Often described as "a heaviness" that developed gradually after implant placement.
Difficulty concentrating, memory lapses, cognitive slowing. Often among the first symptoms reported to improve after explant.
Widespread aching, stiffness, or inflammation — sometimes misdiagnosed as fibromyalgia or early-onset arthritis.
Diffuse thinning or shedding not explained by thyroid or hormonal factors. Commonly reported and commonly resolves post-explant.
Rashes, dryness, sensitivity, or redness — sometimes in patterns consistent with autoimmune presentations, sometimes generalized.
Elevated inflammatory markers, new-onset autoimmune diagnoses (lupus, Sjögren's, Hashimoto's), or symptoms consistent with these conditions.
New or worsening anxiety, mood instability, or depression developing after implant placement — without clear psychological trigger.
Irregular cycles, unexplained hormonal fluctuation, or thyroid-like symptoms in the absence of diagnosed thyroid disease.
Tightness, pressure, or discomfort in the chest area — especially when associated with capsular contracture or implant shifting.
Symptom presentation varies widely between patients. Some women with BII experience one or two symptoms intensely; others show a broader constellation. The free consultation with Dr. Baley is the appropriate first step — not self-diagnosis.
A 45-minute video call with Dr. Baley directly. He will listen to your history, review your imaging if available, and give you an honest assessment of what he recommends — and why. No coordinators. No upsell.



